US Patent Issued to Nucleus Therapeutics, Yale University on May 27 for "Binding proteins 1" (Australian, American Inventors)

ALEXANDRIA, Va., June 17 -- United States Patent no. 12,312,417, issued on May 27, was assigned to Nucleus Therapeutics Pty Ltd. (South Melbourne, Australia) and Yale University (New Haven, Conn.).

"Binding proteins 1" was invented by James Campbell (Melbourne, Australia), Valentina Dubljevic (Melbourne, Australia), James Hansen (Guilford, Conn.), Zahra Rattray (New Haven, Conn.) and Jiangbing Zhou (Cheshire, Conn.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure relates to cell penetrating anti-DNA binding proteins. Compositions comprising these binding proteins may be may be useful for delivering agents to cells and treating diseases such as cancer."

The patent was filed on Feb. 3, 20...